Related Experiment Video
Updated: Sep 9, 2025

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
GRAPPA Patient Research Partner Network Composition and Engagement: A Survey to Determine Strategic Areas for Growth
Christine A Lindsay1, Suzanne M Grieb2, Arnon Katz3
1C.A. Lindsay, PharmD, GRAPPA Patient Research Partner, Prosper, Texas, USA; calindsay1@gmail.com.
Abstract:
The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) Patient Research Partner (PRP) Network conducted a survey to identify its key strengths and gaps, with the goal of enhancing its global reach and representation. The survey revealed strong gender parity and high long-term project participation among PRP members. However, it also indicated a need for greater ethnic and geographical diversity among the members. To address this, the PRP Network will expand its membership and specifically recruit partners from underrepresented regions such as Africa, Asia, Australia/New Zealand, South America, and Eastern Europe. Additionally, the network aims to expand its age range to include a more representative selection of research partners, thereby advancing GRAPPA's overarching objectives. The results of the survey were presented at the GRAPPA 2024 annual meeting.
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Peripheral Artery Disease III: Interprofessional Care
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Patient-centered Care

